Answers are grounded in this paper and cite their sources.
Orally administered second-generation gepants are effective for the treatment of migraine. The intranasal administration of the third-generation gepant zavegepant might have additional benefits including a rapid onset of action, but it is not clear yet to which extent this has clinical relevance.
No takes yet. Share an insight, caveat, or question.
Boucherie et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: